PolyPeptide Group

Samsung Biologics has announced an all-cash public tender offer to acquire Swiss peptide manufacturer PolyPeptide Group AG at CHF 44.31 per share, valuing the company at approximately CHF 1.46 billion ($1.81 billion). The deal, announced on July 20, 2026, marks…